ProCE Banner Activity

Individualizing Care of Patients with Type 2 Diabetes Using GLP-1 RAs: Education By Simulation

Clinical Thought

Using an interactive patient simulation platform, learners are guided through simulated cases to help them identify gaps in their care and improve their performance. Here’s what we learned from practitioners who utilized the platform to work through 2 type 2 diabetes cases related to glucagon-like peptide-1 (GLP-1) receptor agonists. 

Released: December 22, 2022

Expiration: December 22, 2023

No longer available for credit.



Debbie Hinnen

Debbie Hinnen, APN, BC-ADM, CDCES, FAAN

Certified Diabetes Care and Education Specialist
Consultant, University of Colorado Health
Colorado Springs, Colorado


All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Debbie Hinnen APN, BC-ADM, CDCES: consultant/advisor/speaker: Intuity, Lilly/Boehringer Ingelheim, Novo, Sanofi.

The planners and content peer reviewers from Partners for Advancing Clinical Education and Practicing Clinicians Exchange, do not have any relevant financial relationships to disclose.